The 14-3-3 protein family has emerged as a significant regulator in tumorigenesis, marking it as a promising target for tumor therapy.168 These proteins also appear to be pertinent in bone-related tumors, such as OS and synovial sarcoma (Fig. 5). The gene discussed is YWHAQ; the disease is neoplasm.